114 related articles for article (PubMed ID: 37787034)
1. Expression of CD105 but not of E-cadherin is associated with malignancy recurrence and disease-free interval in laryngeal cancer in men.
Zvrko E; Vuckovic L
Folia Histochem Cytobiol; 2023; 61(3):183-192. PubMed ID: 37787034
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
[TBL] [Abstract][Full Text] [Related]
3. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
Li Q; Zhang B; Peng P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
[TBL] [Abstract][Full Text] [Related]
4. CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma.
Zvrko E; Mikic A; Vuckovic L
Eur Arch Otorhinolaryngol; 2009 Dec; 266(12):1971-6. PubMed ID: 19340447
[TBL] [Abstract][Full Text] [Related]
5. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma.
Marioni G; Staffieri A; Manzato E; Ralli G; Lionello M; Giacomelli L; Prosenikliev V; Marchese-Ragona R; Busnardo A; Bolzetta F; Blandamura S
Arch Otolaryngol Head Neck Surg; 2011 Feb; 137(2):175-80. PubMed ID: 21339405
[TBL] [Abstract][Full Text] [Related]
6. CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma.
Marioni G; Ottaviano G; Giacomelli L; Staffieri C; Casarotti-Todeschini S; Bonandini E; Staffieri A; Blandamura S
Eur J Surg Oncol; 2006 Dec; 32(10):1149-53. PubMed ID: 16979866
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic significance of CD105-assessed microvessel density in glottic laryngeal squamous cell carcinoma.
Zvrko E; Mikic A; Vuckovic L
Auris Nasus Larynx; 2010 Feb; 37(1):77-83. PubMed ID: 19553039
[TBL] [Abstract][Full Text] [Related]
8. Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival.
Marioni G; Marino F; Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Lionello M; De Filippis C; Staffieri A
Histopathology; 2010 Oct; 57(4):535-43. PubMed ID: 20955379
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of a panel of two biomarkers (E-cadherin and CD105) in laryngeal cancer.
Zvrko E; Vuckovic L; Radunovic M
Pol J Pathol; 2023; 74(4):225-231. PubMed ID: 38477084
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of microvessel density (MVD) in laryngeal squamous cell carcinoma].
Bodnar M; Szylberg Ł; Kaźmierczak W; Marszałek A
Przegl Lek; 2012; 69(10):726-30. PubMed ID: 23421020
[TBL] [Abstract][Full Text] [Related]
11. [The expressions of TP, MK and CD105 in laryngeal squamous cell carcinoma and their clinical significance].
Liu Y; Xue X; Wang F
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Feb; 22(3):100-3. PubMed ID: 18476626
[TBL] [Abstract][Full Text] [Related]
12. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
[TBL] [Abstract][Full Text] [Related]
13. The EGFR-mTOR pathway and laryngeal cancer angiogenesis.
Lionello M; Lovato A; Staffieri A; Blandamura S; Turato C; Giacomelli L; Staffieri C; Marioni G
Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of angiogenesis-related factors: CD105, EphA2 and EphrinA1 in laryngeal squamous cell carcinoma and clinical implication].
Su J; Ji XB; Xie JH; Li W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 51(12):929-936. PubMed ID: 27978884
[No Abstract] [Full Text] [Related]
15. Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens.
Alessandrini L; Ferrari M; Taboni S; Sbaraglia M; Franz L; Saccardo T; Del Forno BM; Agugiaro F; Frigo AC; Dei Tos AP; Marioni G
Oral Oncol; 2022 Sep; 132():105982. PubMed ID: 35759860
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma.
Ahmed RA; Shawky Ael-A; Hamed RH
Pathol Oncol Res; 2014 Jul; 20(3):625-33. PubMed ID: 24470282
[TBL] [Abstract][Full Text] [Related]
17. CD105- and CD31-assessed microvessel density in laryngeal carcinoma biopsies as a predictor of recurrence after exclusive primary surgery.
Franz L; Alessandrini L; Saccardo T; Frigo AC; Marioni G
Ann Diagn Pathol; 2020 Oct; 48():151608. PubMed ID: 32890907
[TBL] [Abstract][Full Text] [Related]
18. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis.
Martinović Ž; Kovač D; Martinović C
World J Surg Oncol; 2016 Apr; 14():122. PubMed ID: 27102733
[TBL] [Abstract][Full Text] [Related]
19. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
20. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
